Strix
26.1K

CVE-2019-11830

UnknownEPSS 2.67%

Last modified

CVE-2019-11830 is a vulnerability of currently unknown severity. PharMetaDataInterceptor in the PharStreamWrapper (aka phar-stream-wrapper) package 2.x before 2.1.1 and 3.x before 3.1.1 for TYPO3 mishandles Phar stub parsing, which allows attackers to bypass a deserialization protection mechanism.. EPSS estimates a 2.67% chance of exploitation in the next 30 days.

Description

PharMetaDataInterceptor in the PharStreamWrapper (aka phar-stream-wrapper) package 2.x before 2.1.1 and 3.x before 3.1.1 for TYPO3 mishandles Phar stub parsing, which allows attackers to bypass a deserialization protection mechanism.

Metrics

EPSS Probability
2.67%

83.9th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

Affected Software

VendorProductVersions
Typo3Pharstreamwrapper>= 2.0.0, < 2.1.1
Typo3Pharstreamwrapper>= 3.0.0, < 3.1.1

References

Timeline

Published
Last Modified
Status
Modified

Frequently Asked Questions

What is CVE-2019-11830?
PharMetaDataInterceptor in the PharStreamWrapper (aka phar-stream-wrapper) package 2.x before 2.1.1 and 3.x before 3.1.1 for TYPO3 mishandles Phar stub parsing, which allows attackers to bypass a deserialization protection mechanism.
How severe is CVE-2019-11830?
Severity scoring for CVE-2019-11830 is pending analysis. The EPSS model estimates a 2.67% probability of exploitation in the next 30 days.
How do I fix CVE-2019-11830?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2019-11830?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST